Chkadua G, Nozadze E, Tsakadze L, Shioshvili L, Leladze M, Arutinova N
Cell Biochem Biophys. 2025; .
PMID: 40072830
DOI: 10.1007/s12013-025-01716-3.
Rasko N, Nahm C, Turchini J, Teh R, Rasmussen H, Byeon S
Cancer Med. 2025; 14(1):e70500.
PMID: 39783776
PMC: 11714220.
DOI: 10.1002/cam4.70500.
Gan J, Yang L, Yang S, Gu W, Gu Y, Shi Y
J Assist Reprod Genet. 2024; 42(2):665-678.
PMID: 39730944
PMC: 11871252.
DOI: 10.1007/s10815-024-03363-8.
McKenna M, Gong X, Petersen A, Sostaric S, Goodman C, Garnham A
Exp Physiol. 2024; 109(11):1909-1921.
PMID: 39222217
PMC: 11522823.
DOI: 10.1113/EP091962.
Contreras R, Torres-Carrillo A, Flores-Maldonado C, Shoshani L, Ponce A
Int J Mol Sci. 2024; 25(11).
PMID: 38892309
PMC: 11172918.
DOI: 10.3390/ijms25116122.
AMPK and glucose deprivation exert an isoform-specific effect on the expression of Na,K-ATPase subunits in cultured myotubes.
Vidovic A, Dolinar K, Chibalin A, Pirkmajer S
J Muscle Res Cell Motil. 2024; 45(3):139-154.
PMID: 38709429
PMC: 11316707.
DOI: 10.1007/s10974-024-09673-9.
The effect of cytochrome c on Na,K-ATPase.
Chkadua G, Nozadze E, Tsakadze L, Shioshvili L, Arutinova N, Leladze M
J Bioenerg Biomembr. 2024; 56(3):221-234.
PMID: 38517564
DOI: 10.1007/s10863-024-10012-3.
PCDHA9 as a candidate gene for amyotrophic lateral sclerosis.
Zhong J, Wang C, Zhang D, Yao X, Zhao Q, Huang X
Nat Commun. 2024; 15(1):2189.
PMID: 38467605
PMC: 10928119.
DOI: 10.1038/s41467-024-46333-5.
Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration.
Ding F, Sun Q, Long C, Rasmussen R, Peng S, Xu Q
Brain. 2024; 147(5):1726-1739.
PMID: 38462589
PMC: 11068329.
DOI: 10.1093/brain/awae075.
Sensational site: the sodium pump ouabain-binding site and its ligands.
Blaustein M, Hamlyn J
Am J Physiol Cell Physiol. 2024; 326(4):C1120-C1177.
PMID: 38223926
PMC: 11193536.
DOI: 10.1152/ajpcell.00273.2023.
A century of exercise physiology: effects of muscle contraction and exercise on skeletal muscle Na,K-ATPase, Na and K ions, and on plasma K concentration-historical developments.
McKenna M, Renaud J, Ortenblad N, Overgaard K
Eur J Appl Physiol. 2024; 124(3):681-751.
PMID: 38206444
PMC: 10879387.
DOI: 10.1007/s00421-023-05335-9.
HIF-2α Controls Expression and Intracellular Trafficking of the α2-Subunit of Na,K-ATPase in Hypoxic H9c2 Cardiomyocytes.
Baloglu E
Biomedicines. 2023; 11(11).
PMID: 38001879
PMC: 10669276.
DOI: 10.3390/biomedicines11112879.
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
Li M, Nishimura T, Takeuchi Y, Hongu T, Wang Y, Shiokawa D
J Clin Invest. 2023; 133(22).
PMID: 37966117
PMC: 10645391.
DOI: 10.1172/JCI166666.
Hypoxia and HIF-1α Regulate the Activity and Expression of Na,K-ATPase Subunits in H9c2 Cardiomyoblasts.
Gurler B, Gencay G, Baloglu E
Curr Issues Mol Biol. 2023; 45(10):8277-8288.
PMID: 37886965
PMC: 10605391.
DOI: 10.3390/cimb45100522.
Identified and potential internalization signals involved in trafficking and regulation of Na/K ATPase activity.
Hodeify R, Kreydiyyeh S, Zaid L
Mol Cell Biochem. 2023; 479(7):1583-1598.
PMID: 37634170
PMC: 11254989.
DOI: 10.1007/s11010-023-04831-y.
scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content.
Dasargyri A, Gonzalez Rodriguez D, Rehrauer H, Reichmann E, Biedermann T, Moehrlen U
Cells. 2023; 12(12).
PMID: 37371048
PMC: 10296558.
DOI: 10.3390/cells12121577.
Microproteins: Overlooked regulators of physiology and disease.
Hassel K, Brito-Estrada O, Makarewich C
iScience. 2023; 26(6):106781.
PMID: 37213226
PMC: 10199267.
DOI: 10.1016/j.isci.2023.106781.
Hypoxic Stress-Dependent Regulation of Na,K-ATPase in Ischemic Heart Disease.
Baloglu E
Int J Mol Sci. 2023; 24(9).
PMID: 37175562
PMC: 10177966.
DOI: 10.3390/ijms24097855.
High-Intensity Training Represses FXYD5 and Glycosylates Na,K-ATPase in Type II Muscle Fibres, Which Are Linked with Improved Muscle K Handling and Performance.
Hostrup M, Lemminger A, Thomsen L, Schaufuss A, Alsoe T, Bergen G
Int J Mol Sci. 2023; 24(6).
PMID: 36982661
PMC: 10051537.
DOI: 10.3390/ijms24065587.
The Na/K-ATPase: A potential therapeutic target in cardiometabolic diseases.
Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic E
Front Endocrinol (Lausanne). 2023; 14:1150171.
PMID: 36926029
PMC: 10011626.
DOI: 10.3389/fendo.2023.1150171.